Downregulation of AT-rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma

被引:2
|
作者
Li, Wei [1 ]
An, Ning [1 ]
Wang, Mingwei [2 ]
Liu, Xiguo [1 ]
Mei, Zhidan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Dept Head & Neck Surg, 16 Zhuodaoquan S Rd, Wuhan 430079, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China
来源
IMMUNOLOGY AND CELL BIOLOGY | 2023年 / 101卷 / 01期
关键词
AT-rich interaction domain 2; cytotoxicity; natural killer cells; oral squamous cell carcinoma; programmed death-1; TISSUE;
D O I
10.1111/imcb.12602
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system plays a significant role in controlling oral squamous cell carcinoma (OSCC) initiation and progression. Natural killer (NK) cells actively participate in antitumor immunity but become dysfunctional or exhausted in the tumor microenvironment. To explore the mechanisms of NK cell dysfunction in OSCC, we characterized the expression and function of AT-rich interaction domain 2 (ARID2) in NK cells in a murine OSCC model. ARID2 was downregulated in tongue NK cells compared with splenic NK cells. Notably, ARID2 was significantly decreased in NK cells with an exhausted phenotype and weakened antitumor function. ARID2 knockdown resulted in the upregulation of programmed cell death protein 1 (PD-1) and downregulation of interferon-gamma (IFN-gamma), tumor necrosis factor (TNF), granzyme B and perforin in NK cells. As a result, ARID2 knockdown impaired NK cell cytotoxicity. Besides, ARID2 overexpression suppressed the expression of PD-1 and lymphocyte-activation gene 3, and promoted the expression of IFN-gamma, TNF, granzyme B and perforin in NK cells which were adoptively transferred into OSCC-bearing mice. Taken together, our study implies that the OSCC microenvironment triggers ARID2 downregulation in intratumoral NK cells. In turn, ARID2 downregulation results in PD-1 upregulation on NK cells and subsequently impairs NK cell cytotoxicity. Therefore, we uncovered a novel mechanism of NK cell dysfunction in OSCC.
引用
收藏
页码:78 / 90
页数:13
相关论文
共 50 条
  • [31] MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
    Lee, Kah Young
    Oh, Su Young
    Lee, Heon-Jin
    Kwon, Tae-Geon
    Kim, Jin-Wook
    Shin, Chang-Geol
    Hong, Su-Hyung
    Choi, So-Young
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [32] Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma
    Shimomura, Hiroyuki
    Sasahira, Tomonori
    Nakashima, Chie
    Shimomura-Kurihara, Miyako
    Kirita, Tadaaki
    PATHOLOGY, 2018, 50 (06) : 642 - 647
  • [33] Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma
    Guo, Zizhao
    Zhao, Yuxia
    Xu, Meng
    Zhao, Long
    Wang, Xiaolei
    JOURNAL OF GENE MEDICINE, 2024, 26 (02):
  • [34] Metformin-mediated natural killer cell cytotoxicity in head and neck squamous cell carcinoma.
    Crist, McKenzie
    Lehn, Maria
    Wise-Draper, Trisha
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Natural Compounds: DNA Methyltransferase Inhibitors in Oral Squamous Cell Carcinoma
    Jha, Meenakshi
    Aggarwal, Ruchi
    Jha, Abhimanyu Kumar
    Shrivastava, Anju
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2015, 177 (03) : 577 - 594
  • [36] Nanocurcumin: Potential Natural Alkaloid against Oral Squamous Cell Carcinoma
    Khodabux, Rachael Jahander
    Parvathi, Venkatachalam Deepa
    Harikrishnan, Thamizhchelvan
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2021, 5 (03): : 252 - 259
  • [37] Natural Compounds: DNA Methyltransferase Inhibitors in Oral Squamous Cell Carcinoma
    Meenakshi Jha
    Ruchi Aggarwal
    Abhimanyu Kumar Jha
    Anju Shrivastava
    Applied Biochemistry and Biotechnology, 2015, 177 : 577 - 594
  • [38] Downregulation of Notch4-a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma
    Harishankar, M. K.
    Mohan, A. Mathan
    Krishnan, A. Vinod
    Devi, Arikketh
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2019, 85 (01) : 11 - 16
  • [39] Perspective on muscle-tumor interaction in oral squamous cell carcinoma
    Sarode, Sachin C.
    Sarode, Gargi S.
    Sengupta, Namrata
    Sharma, Nilesh Kumar
    Patil, Shankargouda
    ORAL ONCOLOGY, 2020, 109
  • [40] Occult tonsillar squamous cell carcinoma in 2 dogs presenting for treatment of primary oral squamous cell carcinoma
    Rancilio, Nicholas J.
    Fulkerson, Christopher M.
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2018, 59 (10): : 1075 - 1078